CEimpact Podcast CEimpact

Join us this episode as we discuss new recommendations from the American Dental Association on acute pain management.
 
The GameChanger
Dosing acetaminophen and ibuprofen where they peak at the same time due to their synergistic properties, resulting in treatment being often more effective than hydrocodone-apap and oxycodone-apap for pain relief.
 
Guest
Karen Baker, M.S.Pharm., R.Ph
Associate Professor
Colleges of Dentistry and Pharmacy, University of Iowa


Reference
https://www.ada.org/about/press-releases/new-guideline-details-acute-pain-management-strategies-for-adolescent-adult-dental-patients

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Discuss new guideline details on acute pain management for dental patients.
2. Identify how appropriate prescribing for acute dental pain can improve treatment and outcomes.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-157-H01-P
Initial release date: 04/22/2024
Expiration date: X/042/2025
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram

Shortages, access, and cost have led to compounding GLP1s, which has created confusion and misinformation for patients and healthcare providers. Join us as we discuss this practice and delve into what you need to know as a healthcare provider.
THE GAMECHANGER: The advent of GLP1s is a true GameChanger in the health of patients with diabetes, cardiovascular diseases, and obesity, and has led to access issues for manufactured products.
 

Guests
Tenille Davis, PharmD, RPh
Chief Advocacy Officer
Alliance for Pharmacy Compounding
Scott Brunner, CAE
CEO
Alliance for Pharmacy Compounding

Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
https://a4pc.org/advocacy/educating-prescribers/
https://a4pc.org/advocacy/statements-and-other-resources/
https://a4pc.org/files/APC-Compounded-GLP-1s-Media-Brief-REVISED-March-2024.pdf
 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Review criteria for compounding drugs on the FDA drug shortage list.
2. Discuss the facts and misinformation surrounding compounded GLP1 medications.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-145-H01-P
Initial release date: 04/15/2024
Expiration date: 04/15/2025
Additional CPE details can be found here.


Follow CEimpact on Social Media:
LinkedIn
Instagram

This episode discusses the 2023 Inflation Reduction Act and HHS's authority to negotiate prices for high-cost drugs in Medicare Part D. In addition to the initial list of 10 drugs, HHS is now focused on medications used in the hospital and covered under Medicare Part B.
 
The GameChanger
HHS updates the Inflation Reduction Act that will impact over 750, 000 people.
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health

Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Reference
https://www.cms.gov/files/document/reduced-coinsurance-certain-part-b-rebatable-drugs-april-1-june-30-2024.pdf

https://www.hhs.gov/about/news/2024/03/26/hhs-announces-savings-41-prescription-drugs-thanks-inflation-rebates-from-biden-harris-administrations-lower-cost-prescription-drug-law.html?utm_source=MarketingCloud&utm_medium=email&utm_campaign=PT+Daily+March+27&utm_content=PT+Daily+March+27

Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the monetary impact of the Inflation Reduction Act.
2. Discuss how the Medicare Part B drug addition will benefit patients.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-136-H04-P
Initial release date: 4/08/2024
Expiration date: 04/08/2025
Additional CPE details can be found here.


Follow CEimpact on Social Media:
LinkedIn
Instagram

This episode discusses quality and value in healthcare and how the BPCI program, designed to lower costs and enhance care quality, particularly in the post-acute phase, did not demonstrate notable positive impacts on HF-related measures. What does this mean for the larger health quality landscape?
 
The GameChanger
Quality in healthcare is rapidly evolving. There are pressures at the population level that evaluate how we do things; the quality always needs to be safety focused.

Host
Jake Galdo, PharmD, MBA, BCPS, BCGP
CEO
Seguridad

Reference
Article:
Bundled Payments for Care Improvement and Quality of Care and Outcomes in Heart Failure
https://jamanetwork.com/journals/jamacardiology/article-abstract/2813066

 
Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Define quality in healthcare.
2. Review outcomes of hospitals participating in the BPCI program.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-133-H04-P
Initial release date: 04/01/2024
Expiration date: 04/01/2025
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram

The anti-rejection drug rapamycin has been shown in mice and other mammals to reverse cellular damage caused by aging to extend healthy life by up to 20%. This has caused massive off-label prescribing and use of rapamycin in humans as an anti-aging drug.
 
The GameChanger
What do you tell patients about the evidence-based use of rapamycin for anti-aging?
 
Host
Geoff Wall, PharmD, BCPS, FCCP, BCGP
Professor of Pharmacy Practice, Drake University
Internal Medicine/Critical Care, UnityPoint Health
 
Reference
https://www.washingtonpost.com/business/2024/03/15/rapamycin-longevity-drug/
https://www.thelancet.com/journals/lanhl/article/PIIS2666-7568(23)00258-1/fulltext
 Pharmacist Members, REDEEM YOUR CPE HERE!
 
Not a member? Get a Pharmacist Membership & earn CE for GameChangers Podcast episodes! (30 mins/episode)


CPE Information
 
Learning Objectives
Upon successful completion of this knowledge-based activity, participants should be able to:
1. Describe the mechanism of action of rapamycin and how it may reverse normal aging.
2. Discuss the current state of evidence of rapamycin for this indication and its safety concerns.

0.05 CEU/0.5 Hr
UAN: 0107-0000-24-129-H01-P
Initial release date: 03/25/2024
Expiration date: 03/25/2025
Additional CPE details can be found here.
Follow CEimpact on Social Media:
LinkedIn
Instagram

In this episode, we delve into the crucial topic of understanding generational differences in the context of pharmacy education. Our guest expert, Melissa Medina from the University of Oklahoma, brings a wealth of knowledge and experience to the table, shedding light on why grasping these generational nuances is paramount for preceptors working with pharmacy students and residents.

Tune in to gain a fresh perspective on how everyone can win and learn by engaging across generations.
 
Host
Kathy Schott, PhD
Vice President, Education & Operations
CEimpact

Guest
Melissa Medina, Ed.D
Interim Dean and Professor
The University of Oklahoma Health Sciences Center College of Pharmacy

Get CE: CLICK HERE TO GET CPE CREDIT FOR THE COURSE!

CPE Information
 
Learning Objectives
At the end of this course, preceptors will be able to:
Describe factors that have impacted how Generation Z p(Gen Z) pharmacy residents and student pharmacists see the world.Identify strategies for engaging effectively with Gen Z learners.0.05 CEU/0.5 Hr
UAN: 0107-0000-24-111-H99-P
Initial release date: 3/20/2024
Expiration date: 3/20/2027
Additional CPE details can be found here.

The speakers have no relevant financial relationships with ineligible companies to disclose.
ChatGPT 3.5 (https://chat.openai.com) was utilized in the planning of this P2P episode.

This program has been:
Approved by the Minnesota Board of Pharmacy as education for Minnesota pharmacy preceptors.

Reviewed by the Texas Consortium on Experiential Programs and has been designated as preceptor education and training for Texas preceptors.
Follow CEimpact on Social Media:
LinkedIn
Instagram